Evidence map›Paper›PMID 11696603›Full record

ReviewThe Journal of experimental medicine2001

New mechanisms and pathways for monocyte recruitment.

W A Muller

Abstract readCommentReview
In one paragraph

Review in The Journal of experimental medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer's disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. The cytokine network in women with an asymptomatic short cervix and the risk of preterm delivery.American journal of reproductive immunology (New York, N.Y. : 1989) · 2017
    Article
  14. Review
  15. Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Immunological cells and functions in Gaucher disease.Critical reviews in oncogenesis · 2013
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

W A MullerDepartment of Pathology and Graduate Program in Immunology, Weill Medical College of Cornell University, New York, NY 10021, USA. wamuller@med.cornell.edu

Funding

TWO NOVEL VASCULAR ADHESION MOLECULES: PECAM AND HEC-1R01HL046849 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MULLER, WILLIAM A · 1991 to 2019
$6.7M
Beyond PECAM: Mechanisms of Transendothelial MigrationR37HL064774 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MULLER, WILLIAM A · 2005 to 2014
$4.0M
PECAM-INDEPENDENT TRANSENDOTHELIAL MIGRATIONR01HL064774 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI MULLER, WILLIAM A · 2000 to 2020
$3.3M
NHLBI NIH HHS HL46849NHLBI NIH HHS HL64774NHLBI NIH HHS R01 HL046849NHLBI NIH HHS R01 HL064774NHLBI NIH HHS R37 HL064774
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Intercellular Signaling Peptides and ProteinsAnimalsChemokine CCL2Chemokine CXCL9Chemokines, CXCChemotaxis, LeukocyteHumansLeukocytes, MononuclearLymph NodesMonocytesReceptors, Complement 3bChemokine CCL2Chemokine CXCL9Chemokines, CXCCXCL14 protein, humanCXCL9 protein, humanIntercellular Signaling Peptides and ProteinsReceptors, Complement 3b

Identifiers

PMID11696603
PMCPMC2195978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.